Search Results - "DINKELBORG, LUDGER M"

Refine Results
  1. 1

    Specific PET Imaging of xC― Transporter Activity Using a 18F-Labeled Glutamate Derivative Reveals a Dominant Pathway in Tumor Metabolism by KOGLIN, Norman, MUELLER, Andre, BERNDT, Mathias, SCHMITT-WILLICH, Heribert, TOSCHI, Luisella, STEPHENS, Andrew W, GEKELER, Volker, FRIEBE, Matthias, DINKELBORG, Ludger M

    Published in Clinical cancer research (15-09-2011)
    “…(18)F-labeled small molecules targeting adaptations of tumor metabolism possess the potential for early tumor detection with high sensitivity and specificity…”
    Get full text
    Journal Article
  2. 2
  3. 3

    18F-Radiolabeling of Aromatic Compounds Using Triarylsulfonium Salts by Mu, Linjing, Fischer, Cindy R., Holland, Jason P., Becaud, Jessica, Schubiger, P. August, Schibli, Roger, Ametamey, Simon M., Graham, Keith, Stellfeld, Timo, Dinkelborg, Ludger M., Lehmann, Lutz

    Published in European Journal of Organic Chemistry (01-02-2012)
    “…A new method for the 18F‐radiolabeling of aromatic compounds based on the aromatic nucleophilic substitution (SNAr) reaction using triarylsulfonium salts has…”
    Get full text
    Book Review Journal Article
  4. 4
  5. 5

    Radioimmunotherapy of Solid Tumors by Targeting Extra Domain B Fibronectin: Identification of the Best-Suited Radioimmunoconjugate by BERNDORFF, Dietmar, BORKOWSKI, Sandra, SIEGER, Stephanie, ROTHER, Axel, FRIEBE, Matthias, VITI, Francesca, HILGER, Christoph S, CYR, John E, DINKELBORG, Ludger M

    Published in Clinical cancer research (01-10-2005)
    “…Purpose: The expression of extra domain B (ED-B) fibronectin is always associated with angiogenic processes and can be exclusively observed in tissues…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Molecular imaging in drug development by Gambhir, Sanjiv S, Willmann, Jürgen K, van Bruggen, Nicholas, Dinkelborg, Ludger M

    Published in Nature reviews. Drug discovery (01-07-2008)
    “…Key Points Drug development is a costly, time-intensive and high-risk endeavour, with only two to three approvals for novel therapeutics in new drug classes…”
    Get full text
    Journal Article
  7. 7

    Bispecific Antibody Pretargeting of Tumor Neovasculature for Improved Systemic Radiotherapy of Solid Tumors by MOOSMAYER, Dieter, BERNDORFF, Dietmar, DINKELBORG, Ludger M, CHANG, Chien-Hsing, SHARKEY, Robert M, ROTHER, Axel, BORKOWSKI, Sandra, ROSSI, Edmund A, MCBRIDE, William J, CARDILLO, Thomas M, GOLDENBERG, David M

    Published in Clinical cancer research (15-09-2006)
    “…Purpose: Extra domain B (ED-B) fibronectin is a specific tumor matrix marker for targeting angiogenesis in solid tumors. In this study, the radiotherapeutic…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Commentary to 18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots—Are We Getting There? by Stephens, Andrew W., Koglin, Norman, Dinkelborg, Ludger M.

    Published in Molecular imaging (01-01-2018)
    “…Thrombus formation can lead to heart attacks, stroke and pulmonary embolism, which are major causes of mortality. Current standard diagnostic imaging methods…”
    Get full text
    Journal Article
  18. 18

    Commentary to 18 F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots-Are We Getting There? by Stephens, Andrew W, Koglin, Norman, Dinkelborg, Ludger M

    Published in Molecular imaging (01-01-2018)
    “…Thrombus formation can lead to heart attacks, stroke and pulmonary embolism, which are major causes of mortality. Current standard diagnostic imaging methods…”
    Get full text
    Journal Article
  19. 19
  20. 20